UPDATE: Barclays Downgrades Eidos Therapeutics (EIDX) to Underweight
Tweet Send to a Friend
(Updated - February 18, 2020 7:34 AM EST)
(updating comment)Barclays analyst Gena Wang downgraded Eidos Therapeutics (NASDAQ: EIDX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updating comment)Barclays analyst Gena Wang downgraded Eidos Therapeutics (NASDAQ: EIDX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
